Trails Edge Capital Partners, LP - 17 Feb 2026 SCHEDULE 13G Report for Immunic, Inc. Common Shares, no par value per share (IMUX)

Filing Manager
Trails Edge Capital Partners, LP
Reporting Manager
Trails Edge Capital Partners, LP
Security
Immunic, Inc. Common Shares, no par value per share
Symbol
IMUX
Shares outstanding
131,655,172 shares
Disclosed Ownership
11,454,000 shares
Ownership
8.7%
Form type
SCHEDULE 13G
Filing time
24 Feb 2026, 16:15:14 UTC
Date of event
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Trails Edge Capital Partners, LP 8.7% 11,454,000 11,454,000 0 /s/ Trails Edge Capital Partners, LLC, GP of Trails Edge Capital Partners, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge Capital Partners, LLC
Trails Edge Biotechnology Master Fund, LP 8.7% 11,454,000 11,454,000 0 /s/ Trails Edge GP, LLC, GP of Trails Edge Biotechnology Fund GP, LP, GP of Trails Edge Biotechnology Master Fund, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge GP, LLC
Ortav Yehudai 8.7% 11,454,000 11,454,000 0 /s/ Ortav Yehudai Ortav Yehudai / Individual